- Home
- PGEN vs GSL Comparison
PGEN vs GSL Comparison
Compare PGEN & GSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PGEN | GSL |
|---|---|---|
| Founded | 1998 | 2007 |
| Country | United States | Greece |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.3B |
| IPO Year | N/A | 2006 |
Fundamental Metrics
Financial Performance| Metric | PGEN | GSL |
|---|---|---|
| Price | $4.76 | $37.35 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | $7.67 | ★ $39.00 |
| AVG Volume (30 Days) | ★ 3.8M | 319.3K |
| Earning Date | 03-18-2026 | 03-04-2026 |
| Dividend Yield | N/A | ★ 6.58% |
| EPS Growth | N/A | ★ 24.38 |
| EPS | N/A | ★ 11.14 |
| Revenue | $6,309,000.00 | ★ $747,044,000.00 |
| Revenue This Year | $342.78 | $7.45 |
| Revenue Next Year | $478.46 | N/A |
| P/E Ratio | ★ N/A | $3.41 |
| Revenue Growth | ★ 59.20 | 6.50 |
| 52 Week Low | $1.11 | $17.73 |
| 52 Week High | $5.23 | $38.14 |
Technical Indicators
Market Signals| Indicator | PGEN | GSL |
|---|---|---|
| Relative Strength Index (RSI) | 58.07 | 60.46 |
| Support Level | $4.37 | $36.47 |
| Resistance Level | $4.88 | $38.14 |
| Average True Range (ATR) | 0.40 | 0.90 |
| MACD | 0.01 | 0.11 |
| Stochastic Oscillator | 71.03 | 67.72 |
Price Performance
Historical ComparisonAbout PGEN Precigen Inc.
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.
About GSL Global Ship Lease Inc New
Global Ship Lease Inc operates in the container shipping industry. The company owns and charters out containerships under long-term, fixed-rate charters to container liner companies. The majority of the company's revenues are derived from charters to MAERSK. Its fleet consisted of more than 60 containerships.